KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Payables (2017 - 2025)

Aurora Cannabis has reported Payables over the past 9 years, most recently at $93.1 million for Q4 2025.

  • Quarterly Payables fell 13.8% to $93.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93.1 million through Dec 2025, down 13.8% year-over-year, with the annual reading at $79.3 million for FY2025, 21.26% down from the prior year.
  • Payables was $93.1 million for Q4 2025 at Aurora Cannabis, up from $79.3 million in the prior quarter.
  • Over five years, Payables peaked at $108.0 million in Q4 2024 and troughed at $41.9 million in Q4 2021.
  • The 5-year median for Payables is $79.3 million (2025), against an average of $74.5 million.
  • Year-over-year, Payables crashed 72.56% in 2021 and then soared 136.33% in 2022.
  • A 5-year view of Payables shows it stood at $41.9 million in 2021, then surged by 97.67% to $82.8 million in 2022, then increased by 13.15% to $93.7 million in 2023, then increased by 15.25% to $108.0 million in 2024, then dropped by 13.8% to $93.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Payables are $93.1 million (Q4 2025), $79.3 million (Q3 2025), and $101.9 million (Q2 2025).